The Calmer Co International (ASX: CCO) has announced the appointment of veteran beverage executive James S. Tonkin as its new chair, following the resignation of John Homewood on the first anniversary of his appointment.
Mr Tonkin’s appointment comes as the company ramps up its US market strategy, targeting the growing demand for natural kava-based products as functional relaxation and alcohol alternatives gain traction among US consumers.
The company said the leadership transition aligns with its next phase of expansion, building on a year of operational turnaround and increasing international sales momentum.
Contribution Acknowledged
The board paid tribute to Mr Homewood’s contribution in stabilising the business during his tenure, along with strengthening its management team and board composition to set a foundation for breakeven and sustainable growth.
Mr Homewood said it had been a privilege to guide the company through a key stage of its development.
“The management team led by Zane Yoshida, together with the Board, has positioned the business for long-term success,” he said.
“I am confident that James Tonkin is the right person at the right time to lead the Board as the company enters its next phase of expansion.”
Deep US Experience
Mr Tonkin has been involved with The Calmer Co since its inception, working closely with founder and chief executive officer Zane Yoshida and serving on the board before the company’s 2018 initial public offering.
With more than four decades in the food and beverage sector, he is recognised internationally as a brand and product development specialist and has advised leading companies including Essentia Water, Zico Coconut Water, Anheuser-Busch, POKKA Japan, Arnold Palmer Tea, and Fiji Water.
“I want to acknowledge John Homewood for his leadership and dedication during a pivotal period in the Company’s turnaround,” Mr Tonkin said.
“The US market presents an extraordinary opportunity, and our team is well-positioned to expand our presence as awareness and demand for noble kava continue to grow.”
Expanding Market Opportunity
Recent research indicates that more than 10% of US adults consumed kava within the past year, highlighting the category’s rapid growth and increasing mainstream acceptance.
The company said its participation at the SupplySide Global 2025 event in Las Vegas further reinforced industry interest in its premium kava products—which include drinking powders, shots, concentrates, and capsules sold under the Fiji Kava, Taki Mai and Danodan Hempworks brands.
The Calmer Co continues to strengthen its relationships with distributors, retailers and formulation partners in North America, leveraging rising consumer interest in plant-based relaxation and stress-relief alternatives to alcohol.
The company said the leadership transition supports a clear focus on international growth while maintaining its commitment to sustainable supply chains and the promotion of Pacific-sourced noble kava products.
